Written by
in
At the 2025 American College of Allergy, Asthma, & Immunology (ACAAI) Annual Scientific Meeting in Orlando, Weilly Soong, MD, from AllerVie Health – Homewood in Birmingham, AL, presented phase 2 data showing povorcitinib provides rapid…